Hematology & Oncology Doctors in Norwood, MA - Medicare Status, Address, Contact

2 Hematology & Oncology doctors found. Showing 1 - 2

Dr. James D Popkin, M.D.
Internal Medicine - Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 825 Washington St, Suite 340, Norwood, MA 02062
Phone: 781-769-6430 Fax: 781-762-0634

Dr. Karen Dietrich Scanlan, M.D.
Internal Medicine - Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 825 Washington St, Suite 340, Norwood, MA 02062
Phone: 781-762-5586 Fax: 781-762-0634

News Archive

Researchers discover novel protein that governs metastasis and chemoresistance in pediatric bone cancer

Human osteosarcoma samples are hard to come by, making the disease difficult to study. However, K9 bone cancer is genetically indistinguishable from the human form of the disease, and over 10,000 canine patients develop the disease every year.

Crossover vote or lost cause? Maine Sen. Collins reform vote examined

Sen. Susan Collins, Maine's junior senator, has a lot of people asking her which way she's leaning on supporting health care reform. And she's remaining mum.

Kidneys of healthy adults show signs of chronic mild injury that increase with age: Mayo Clinic

Mayo Clinic researchers have found that the kidneys of healthy adults show signs of chronic mild injury that increase with age. This damage is present even though the adults showed no clinical signs of kidney disease. The findings are reported in the current issue of the, Annals of Internal Medicine.

ImmunID, Centre Léon Bérard and Cytheris commence CYT107-XELODA Phase IIa trial in metastatic breast cancer

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre Léon Bérard, the major cancer research and treatment center for the Rhône-Alpes region of France, and ImmunID Technologies SAS, a diagnostic company specialized in innovative immunomonitoring tests and services, today announced initiation of a Phase IIa clinical trial that will evaluate multiple combinations of recombinant human interleukin-7, the investigational multifunctional cytokine under development by Cytheris, and a chemotherapeutic agent, XELODA, in the treatment of metastatic breast cancer.

Immune marker predicts infection risk in critically ill children with traumatic injuries

Researchers studying critically ill children with traumatic injuries have identified an immune marker that predicts which patients are likely to develop a hospital-acquired infection.

Hematology & Oncology Doctors in Norwood, MA Accepting Medicare